Home
+
About Us
Welcome Video
Company Overview
Our Purpose
A Message from our CEO
Testimonials
+
Leadership
Executive Team
Legal Team
Careers
Giving Back
Locations
Contact
Phia Certification
Diversity & Inclusion
Privacy Statement
Covid-19 Resources
+
Services
Learn - Independent Consultation & Evaluation
Plan - Phia Document Management
Plan - Plan Drafting Services
Save - Claims, Recovery & Subrogation Services
Save - Claim Negotiation
Save - Phia Unwrapped
Protect - Plan Appointed Claim Evaluator (PACE)
Protect - Patient Defender & Balance Billing
Phia International
-
Media
Covid-19
Webinars
Newsletters
Publications
Blog
Press Releases
Podcasts
Industry Terms
Guide to Understanding Subrogation
Moving To Self-Funded Health Plan Guide
Referenced-Based Pricing Explained
Hospital Price Transparency Guide
Balance-Billing: What Patients Need To Know
Employee Rights With COVID-19 Vaccines
The No Surprises Act Explained
Mental Health Parity and Addiction Equity Act Explained
Understanding Non-Quantitative Treatment Limitations (NQTLs)
The Insulin Cap Bill Offers Hope for Americans With Diabetes
+
Members Area
+
FAQs
FAQ - Subrogation & Reimbursement
FAQ - Mass Tort Subrogation & Reimbursement
Questionnaire Response
Make A Payment
888-986-0080
info@phiagroup.com
Questionnaire Response
Blog
Podcasts
|
Login
Home
About Us
Welcome Video
Company Overview
Our Purpose
A Message from our CEO
Testimonials
Leadership
Executive Team
Legal Team
Careers
Giving Back
Locations
Contact
Phia Certification
Diversity & Inclusion
Privacy Statement
Covid-19 Resources
Services
Learn - Independent Consultation & Evaluation
Plan - Phia Document Management
Plan - Plan Drafting Services
Save - Claims, Recovery & Subrogation Services
Save - Claim Negotiation
Save - Phia Unwrapped
Protect - Plan Appointed Claim Evaluator (PACE)
Protect - Patient Defender & Balance Billing
Phia International
Media
Covid-19
Webinars
Newsletters
Publications
Blog
Press Releases
Podcasts
Industry Terms
Guide to Understanding Subrogation
Moving To Self-Funded Health Plan Guide
Referenced-Based Pricing Explained
Hospital Price Transparency Guide
Balance-Billing: What Patients Need To Know
Employee Rights With COVID-19 Vaccines
The No Surprises Act Explained
Mental Health Parity and Addiction Equity Act Explained
Understanding Non-Quantitative Treatment Limitations (NQTLs)
The Insulin Cap Bill Offers Hope for Americans With Diabetes
Members Area
FAQs
FAQ - Subrogation & Reimbursement
FAQ - Mass Tort Subrogation & Reimbursement
Questionnaire Response
Make A Payment
Posts
Media
>
Posts
Covid-19
Webinars
Newsletters
Publications
Blog
Press Releases
Podcasts
Industry Terms
Guide to Understanding Subrogation
Moving To Self-Funded Health Plan Guide
Referenced-Based Pricing Explained
Hospital Price Transparency Guide
Balance-Billing: What Patients Need To Know
Employee Rights With COVID-19 Vaccines
The No Surprises Act Explained
Mental Health Parity and Addiction Equity Act Explained
Understanding Non-Quantitative Treatment Limitations (NQTLs)
The Insulin Cap Bill Offers Hope for Americans With Diabetes
Phia Group Media
Phia Group Media
Canadian Drug Importation – Back on Track (but not for everyone)
On July 19, 2021
Learn about what the Biden administration clarified regarding the future of fully legal foreign drug importation programs in the recent executive order.
Empowering Plans: P111 – Breaking Down Drug Importation!
On June 11, 2021
Listen to this podcast discussing state drug importation programs. Learn about whether a participant can be a plan fiduciary after a third party recovery.
New Rules on Prescription Drug Importation Are Released – Or Are They?
On August 11, 2020
On July 4, 2020, an "Executive Order on Increasing Drug Importation to Lower Prices for American Patients" was issued. Is this a real step forward? Read on.